Millennium Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Buy
+500
New +$256K 0.14% 116

Other funds holding VRTX

Millennium Capital Advisors's VRTX Position: Q3 2026 in Review

Millennium Capital Advisors opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 500 shares worth $261K. The stake represents 0.14% of the portfolio and ranks #116 among its holdings.

1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Millennium Capital Advisors held 500 shares of Vertex Pharmaceuticals worth $261K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Millennium Capital Advisors position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.14% of Millennium Capital Advisors's portfolio in Q3 2026, its #116 holding.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Millennium Capital Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.